KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to -$39.0 million.

  • Medtronic's Exchange Rate Effect fell 107500.0% to -$39.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $181.0 million, marking a year-over-year increase of 85263.16%. This contributed to the annual value of $188.0 million for FY2025, which is 18173.91% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Exchange Rate Effect is -$39.0 million, which was down 107500.0% from $67.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Exchange Rate Effect ranged from a high of $540.0 million in Q1 2023 and a low of -$175.0 million during Q4 2023
  • Its 5-year average for Exchange Rate Effect is $2.6 million, with a median of -$37.5 million in 2022.
  • Per our database at Business Quant, Medtronic's Exchange Rate Effect soared by 160000.0% in 2023 and then plummeted by 107500.0% in 2025.
  • Quarter analysis of 5 years shows Medtronic's Exchange Rate Effect stood at -$9.0 million in 2021, then crashed by 1022.22% to -$101.0 million in 2022, then tumbled by 73.27% to -$175.0 million in 2023, then surged by 102.29% to $4.0 million in 2024, then crashed by 1075.0% to -$39.0 million in 2025.
  • Its last three reported values are -$39.0 million in Q4 2025, $67.0 million for Q3 2025, and $283.0 million during Q2 2025.